Photopheresis Products Market Trend, Share, Growth, Size Analysis and Forecast 2032

Photopheresis Products Market Industry Prospective

The global Photopheresis Products Market size was valued at USD 282.53 Million in 2023 and is predicted to reach USD 445.86 Million by the end of 2032. The market is expected to grow with a CAGR of 5.2% during the forecast period. The report analyzes the global Photopheresis Products Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Photopheresis Products Market..

Request Free Sample

Photopheresis Products Market Overview

The report covers forecasts and analyses for the photopheresis products market on a global and regional level. The study provides historic data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Million). The study includes drivers and restraints for the photopheresis products market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities and various trends in the photopheresis products market on a global level.

Request Free Sample

To know more about this report, request a sample copy.

Photopheresis Products Market Overview

Photopheresis is a form of photodynamic therapy in which blood is treated with a blood-sensitizing agent irradiated with a specific wavelength of light. Worldwide demand for photopheresis products is growing at a rapid pace. The increasing prevalence of autoimmune diseases and growing counts of organ transplant cases are major factors driving the global photopheresis products market.

Photopheresis Products Market Growth Dynamics

Growing health care infrastructure, improvement in advanced technologies, and a rising geriatric population are factors that will further drive the market. Moreover, photopheresis products are more effective and safe. Increased government reimbursement policies and growing private health care insurance, growing awareness among people are the factors to drive the market for a given forecast period.

Additionally, the wide adoption of technological advancements and growing aging population, and changing lifestyles are some factors that are responsible for the growth of the photopheresis products market. Also, the emergence of new photopheresis centers triggered by growing transplantations, faster approval of regulatory bodies, and increasing adoption of these devices will further drive the global photopheresis products market. However, very high cost of ECP therapy and low penetration of ECP therapy centers are some factors that will hinder the growth of the photopheresis products market in the coming future.

Photopheresis Products Market Segmentation Analysis

Based on product, the photopheresis products market is segmented into open systems and closed systems. Among them, closed system segment held the maximum revenue in 2023. This was due to its evolved technologies and growing prevalence of the autoimmune disease. The closed system is more popular among physicians due to its flexible usage as compared to other available systems.

Based on therapeutic area, the photopheresis products market is segmented into autoimmune diseases, graft versus host diseases, solid organ transplant rejections, and cutaneous T-Cell lymphoma. Among them, autoimmune diseases application recorded a maximum revenue share in 2023. This was due to growing hospital infrastructure and growing consumable disposable income. A large share of autoimmune diseases is due to unhealthy lifestyles, genetic predeposition, and a growing population on large scale. Also, graft versus host diseases is expected to witness the fastest growth rate in this segment.

North America dominated the global photopheresis products market in 2023. The presence of a large number of autoimmune disease patients, growing awareness among people, and well and properly structured reimbursement scenarios from the government for various diseases such as CTL, lung transplantation, and GVHD are factors that mainly drive the market in North America.

Also growing counts of organ transplant cases and growing aging population along with growing consumable disposable income will further contribute for the growth of market in North America. Also high presence of prominent players in this region, continuous research and development activities, and technological advancements are factors which drive market in North America. Asia Pacific market which held only about 4% of the global market in 2015, accounted for about 6.6% CAGR in 2017.

Photopheresis Products Market: Report Scope

Various factors such as increased acceptance of advanced photopheresis devices, advanced research, and faster regulatory approvals are some major drivers of photopheresis products in Asia pacific.

Key Market Players & Competitive Landscape and Segments

Some of the key players in the photopheresis products market include

• Med Tech Solutions GmbH
• Fresenius Kabi AG
• Mallinckrodt Pharmaceuticals
• Macopharma
• Terumo Corporation
• Haemonetics Corporation
• Terumo Corporation
• and Mallinckrodt Pharmaceuticals, among others.

Global Photopheresis Products Market: Product Type Segments

• Open system
• Closed system

Global Photopheresis Products Market: Therapeutic area Segments

• Autoimmune diseases
• Graft versus host diseases
• Solid organ transplant rejections
• Cutaneous T-Cell Lymphoma

Global Photopheresis Products Market: Regional Segments 

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa